Meise Esther, Bertsche Thilo, Jeschke Sarah, Bertsche Astrid, Neininger Martina P
University Medicine Greifswald, Hospital for Children and Adolescents, Department of Neuropaediatrics, Greifswald, Germany; University Medicine Rostock, Hospital for Children and Adolescents, Department of Neuropaediatrics, Rostock, Germany; German Center for Child and Adolescent Health (DZKJ), Partner Site Greifswald/Rostock, Greifswald, Germany.
Leipzig University, Medical Faculty, Institute of Pharmacy, Clinical Pharmacy, and Leipzig University and University Hospital, Drug Safety Center, Leipzig, Germany.
Epilepsy Res. 2025 Jul;213:107548. doi: 10.1016/j.eplepsyres.2025.107548. Epub 2025 Apr 4.
Adverse drug reactions (ADRs) occur frequently in the treatment with antiseizure medication (ASM). We investigated the influence of experienced ADRs on desired or actual treatment modifications in paediatric patients from the parents' perspective.
We interviewed 104 parents of children with an epilepsy diagnosis in routine paediatric care at a German university hospital. The questionnaire comprised questions about current and previous experiences with ASM regarding ADRs leading to desired or actual treatment modifications.
Of 94 parents of children with current ASM, 11/94 (12 %) desired treatment modifications because of ADRs. Of 66 parents of children with previous ASM treatment, 51/66 (77 %) reported a total of 72 actual ADR-related modifications in the past. The most frequently mentioned ADRs leading to desired or actual treatment modifications were fatigue (current: 7/94 [7 %]; previous: 23/72 [32 %]), behavioural changes (current: 6/94 [6 %]; previous: 28/72 [39 %]), and negative changes in cognitive processes (current: 3/94 [3 %]; previous: 12/72 [17 %]). In total, parents attributed ADR-related desired or actual treatment modifications to 14 different ASMs. Behavioural changes leading to desired or actual modifications were mentioned for 10/14 (71 %) ASMs, fatigue for 9/14 (64 %) ASMs, and negative changes in cognitive processes for 8/14 (57 %) ASMs.
One-in-ten parents desired to modify current ASM treatment due to ADRs, and almost two thirds reported actual ADR-related modifications of previous ASMs. As the same ADRs were reported for different ASMs, those ADRs may not be preventable through ASM variation. Thus, coping strategies are needed, particularly for the occurrence of common neurological and psychiatric ADRs.
抗癫痫药物(ASM)治疗中药物不良反应(ADR)频繁发生。我们从家长的角度调查了经历过的ADR对儿科患者期望的或实际的治疗调整的影响。
我们采访了德国一家大学医院常规儿科护理中104名癫痫患儿的家长。问卷包含有关当前和以前使用ASM时因ADR导致期望的或实际的治疗调整的经历的问题。
在94名当前正在使用ASM的患儿家长中,11/94(12%)因ADR希望调整治疗。在66名曾使用过ASM治疗的患儿家长中,51/66(77%)报告过去总共发生了72次与ADR相关的实际治疗调整。导致期望的或实际的治疗调整的最常提及的ADR是疲劳(当前:7/94 [7%];以前:23/72 [32%])、行为改变(当前:6/94 [6%];以前:28/72 [39%])以及认知过程的负面变化(当前:3/94 [3%];以前:12/72 [17%])。家长们总共将与ADR相关的期望的或实际的治疗调整归因于14种不同的ASM。导致期望的或实际的调整的行为改变在14种ASM中的10种(71%)中被提及,疲劳在9种(64%)中被提及,认知过程的负面变化在8种(57%)中被提及。
十分之一的家长因ADR希望调整当前的ASM治疗,近三分之二的家长报告了以前ASM治疗中与ADR相关的实际调整。由于不同的ASM报告了相同的ADR,通过更换ASM可能无法预防这些ADR。因此,需要应对策略,特别是针对常见的神经和精神ADR的发生。